Next, to understand the underlying mechanistic role of dinaciclib, we analyzed the effects of dinaciclib on its molecular targets (CDK2/5/9) and other pro-proliferative genes in CHNG6 and established CCA cell lines (KMCH and HuCCT1). The gene discussed is CDK2; the disease is cholangiocarcinoma.